[1] 仇方忻,史新正,李浩,等. 维持性血液透析合并继发性甲状旁腺功能亢进患者骨代谢及骨密度变化[J]. 中国血液净化,2016,15(7):332-335. [2] 仇方忻,张宁,殷玉磊,等. 维持性血液透析患者血清尿酸与心脏瓣膜钙化的关系[J]. 中国中西医结合肾病杂志,2018,19(8):689-692.[3] Li J, Li A , Wang J, et al. Early Left Ventricular Dysfunction Detected by Speckle Tracking in Long-Term Hemodialysis Patients with Valvular Calcification[J]. Cardiorenal Med, 2018, 9 (1): 22-30. [4] Hirschberg K, Reinhart M, Mereles D, et al. Echocardiographic calcification score in patients with low/intermediate cardiovascular risk[J]. Clin Res Cardiol, 2019,108 (2): 194-202. [5] 张旭升,黄战军,曾宪钦,等.高尿酸血症对血管钙化作用机制的实验性研究[J]. 实用医药杂志,2017,34(4):342-344. [6] Le Quang K, Bouchareb R, Lachance D, et al. Early development of calcific aortic valve disease and left ventricular hypertrophy in a mouse model of combined dyslipidemia and type 2 diabetes mellitus[J]. Arterioscler Thromb Vasc Biol, 2014, 34: 2283-2291. [7] 刘莹,程李涛,唐子勇,等. 血液透析患者家庭自测血压与透析日血压的相关性研究[J].中国血液净化,2014,13(12):819-823. [8] KDIGO clinical practice guideline for the diagnosis, valuation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder(CKD-MBD)[J]. Kidney Int, 2009(S113):S1-S130. [9] Dayanand P , Sandhyavenu H, Dayanand S, et al. Role of Bisphosphonates in Vascular calcification and Bone Metabolism: A Clinical Summary[J]. Curr Cardiol Rev, 2018, 14 (3): 192-199. [10] Liu DD, zhang JC, Zhang Q, et al. TGF-β/BMPsignaling pathway is involved in cerium-promoted osteogenic differentiation of mesenchymal stem cell[J]. J Cell Biochem, 2013, 114(5):1105-1l 14. [11] Burotto M, Chiou VL, Lee JM, et al. The MAPK pathway across different malignancies: A new perspective[J]. Cancer, 2014, 120(22): 3446-3456. [12] 吴燕升,贺斐,高建东. 尿酸诱导氧化应激致肾损害的实验研究进展[J].中国中西医结合肾病杂志,2016,17(2):162-164.[13] 卢永新,杨毕,杨崇猛,等. 慢性肾脏病合并高尿酸血症的治疗研究进展[J]. 临床肾脏病杂志,2018,18(2):124-126. [14] 苏军,孙义军,仇方忻. 维持性血液透析患者血清脂蛋白(a)与左心室结构和功能的关系[J]. 国际泌尿系统杂志,2019,39(2):290-293. [15] 张祖隆,王蕴倩. 慢性肾衰患者血浆脂蛋白相关磷脂酶A2与动脉粥样硬化的关系[J]. 中国动脉硬化杂志,2011,19(2):143-146.[16] 吴永娣,张坤,高静伟,等. 高尿酸血症与血管钙化的关系[J]. 中华心血管病杂志,2017,45(10):902-905. [17] 张健瑜,黄裕立,苏亮,等. 脂蛋白(a)与老年退行性心脏瓣膜病的关系[J]. 中国老年学杂志,2014,34(21):6018-6020. [18] Xie J, Yi Q. Beta2-microglobulin as a potential initiator of inflammatory responses[J]. Trends Immunol, 2003,24(5):228-229. [19] Grossman C, Shemesh J, Koren-Morag N, et al. Serum uric acid is associaled with coronary artery calcification[J]. J clin Hypertens(Greenwich),2014,16(6):424-428. [20] Lee CT, Chua S, Hsu CY, et al. Biomarkers associated with vascular and valvular calcification in chronic hemodialysis patients[J]. Dis Markers,2013,34(4):229-235. [21] Cho JH, Lee DY, Lee ES, et al. Increased risk of coronary artery calcification progression in subjects with high baseline Lp(a) levels: The Kangbuk Samsung Health Study[J]. Int J Cardiol, 2016 ,222:233-237. [22] Jadoul M, Drüeke TB. β2 microglobulin amyloidosis:an update 30 years later[J]. Nephrol Dial Transplant, 2016, 31 (4): 507-509. [23] Ikee R, Honda K, Oka M, et al. Association of heart valve calcification with malnutrition-inflammation complex syndrome, beta- microglobulin, and carotid intima media thickness in patients on hemodialysis[J]. Ther Apher Dial, 2008,12:464-468. |